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SCID mouse spleen does not support scrapie agent replication 
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1 United States Department of  Agriculture, Agricultural Research Service, Animal Disease Research Unit, Pullman, 
Washington 99164-7030 and 2 Washington Animal Disease Diagnostic Laboratory, Washington State University, 
Pullman, Washington 99164-7034, U.S.A. 
BALB/c and severe combined immunodeficiency (SCID) 
mice were inoculated intracerebrally or intraperitoneally 
with scrapie agent strain ME7 to examine the role of 
functional lymphocytes and follicular dendritic cells in 
splenic infectivity and PrP sc accumulation. Intra- 
cerebrally inoculated BALB/c and SCID mice developed 
the clinical signs and microscopic lesions characteristic 
of scrapie. Spleens from terminally affected BALB/c 
mice contained PrP s° which was detectable by immuno- 
blot analysis; SCID mouse spleens did not contain 
detectable PrP so. SCID mouse spleens collected during 
the first 90 days after intraperitoneal infection contained 
neither infectivity nor PrP s°. 
Sheep scrapie is the archetype of a heterogeneous group 
of rare transmissible spongiform encephalopathies 
(TSEs) occurring naturally in humans, cattle, mink, cats 
and captive deer (Hartsough & Burger, 1965; Williams & 
Young, 1980; Wells et al., 1987; Leggett et al., 1990; 
Brown & Gajdusek, 1991). The histopathological lesions 
of TSEs are restricted to the nervous ystem (Chandler, 
1969). However, immunohistochemical and biochemical 
analyses detect a host cellular membrane glycoprotein, 
the prion protein (PrP c) (Prusiner, 1982; Oesch et al., 
1985; Basler et al., 1986), that accumulates in lymphoid 
and nervous tissues as a relatively protease-resistant 
isoform [PrP s~ in scrapie-infected animals and PrP cJD in 
Creutzfeldt-Jakob disease (CJD)-infected animals] (Merz 
et al., 1987; Doi et al., 1988; Farquhar et al., 1989; 
Kitamoto et al., 1989; Race et al., 1992). PrP sc is tightly 
associated with infectivity and may either contain or be 
the infectious agent itself (Diringer et al., 1983 ; McKinley 
et al., 1983; Merz et al., 1984, 1987). Infectivity and PrP sc 
accumulation i the spleen are detectable within 2 weeks 
of experimental infection in rodents and persist hrough- 
out the incubation period (Eklund et al., 1967; Race & 
Ernst, 1992). Scrapie infectivity in the spleen is associated 
with post-mitotic non-lymphoid (stromal) cells and is 
unaffected by thymectomy (McFarlin et al., 1971; 
Worthington & Clark, 1971 ; Clarke & Kimberlin, 1984; 
Robinson & Gorham, 1990). PrP c in normal mouse 
spleens and prpSc/prP cJD accumulation in infected 
mouse spleens is restricted to cells with the morphological 
characteristics and antigen-trapping capacity of follicular 
dendritic ells (FDCs) (Kitamoto et al., 1991; McBride et 
al., 1992). In spite of these similarities, the splenic 
replication phase is not obligatory in all rodent TSE 
models. Prion mRNA is detectable in mouse spleens by 
Northern blot analysis (Caughey et al., 1988) and PrP c is 
detectable by immunoblot and immunofluorescence 
analysis of hamster leukocytes and spleens (Bendheim et 
al., 1992). 
Severe combined immunodeficiency (SCID) mice, 
which lack functional FDCs secondary to the absence of
lymphocytes (Kapasi et al., 1993), do not develop clinical 
signs of CJD or accumulation ofsplenic PrP eJD following 
intraperitoneal (i.p.) inoculation (Kitamoto et al., 1991), 
although CJD is readily transmitted to SCID mice by the 
intracerebral (i.c.) route. To extend this observation, we 
have examined splenic infectivity and PrP s° accumulation 
in SCID mice inoculated with scrapie agent strain ME7. 
Homozygous C.B.-17-SCID/SCID female mice, 3 
weeks of age, were obtained from Taconic Laboratories 
and normal 3-week-old female BALB/c mice were 
obtained from B&K Universal. All mice were housed in 
groups of two to four animals in microisolator cages and 
given autoclaved food and water. Scrapie agent strain 
ME7 was obtained as whole frozen brains from termin- 
ally infected C57BL mice. A 10 % (w/v) brain suspension 
was prepared using sterile Tris-buffered saline (TBS; 
0'05 M-Tris-HC1 pH 7'8, 0.1 M-NaC1) in a sterile glass 
Dounce homogenizer and frozen at -20  °C until 
required. Mice were inoculated by the i.e. route with 
30 gl or by the i.p. route with 100 gl of freshly thawed 
10 % brain homogenate or with dilutions made in sterile 
TBS. Controls included untreated mice and mice inocu- 
lated with similar volumes of a 10% homogenate of 
uninfected C57BL brain or with TBS alone. Mice were 
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Animals affected/number inoculated 
[incubation range (days)] 
BALB/c SCID 
1 3/3 (146-147) 2/2 (157) 
-2  3/3 (161 180) 3/3 (176) 
-3  4/4 (161-182) 2/2 (176~179) 
-4  4/4(171 196) 3/3 (184) 
-5  4/4(189 198) 3/3 (198) 
-6  3/3 (243) ~D* 
-7  4/4 (252) ND 
-8  0/4t ND 
* ND, Not done. 
t Animals euthanized at 426 days p.i. 
Table 2. Infectivity bioassay of spleens from i.p. 
inoculated BALB/c and SCID mice 
Animals affected/number inoculated 
[incubation range (days)] 
Time p.i. 
(days) BALB/c donor SCID donor 
30 16/16 (167 196) 0/16 
60 15"/15 (t64-174) 0/16 
90 16/16 (174~20l) 0/16 
* Excludes one mouse which died within 24 h of inoculation. 
observed aily for clinical signs (ruffled fur, lethargy, 
ataxia) and euthanized either when clearly moribund or 
3 weeks after lethargy was first noted. Incubation times 
are reported as days from inoculation to euthanasia or 
death. The i.c. infectious titre of the inoculum was 
109LDs0/ml (Reed & Muench, 1938; Eklund et al., 
1967). Inoculation (i.c.) of SCID mice with the five 
lowest dilutions of the inoculum resulted in incubation 
periods (Table 1) similar to those observed in BALB/c 
mice. Histopathological examination of the brains of 
representative affected BALB/c and SCID mice showed 
focal spongiosis, astrocytosis and rare intraneuronal 
vacuolation (not shown). 
Infectivity in the spleens of i.p.-inoculated SCID and 
BALB/c mice was determined at 30, 60 and 90 days post- 
inoculation (p.i.). Spleens were collected from individual 
ME7-infected BALB/c or SCID mice and from uninfec- 
ted control mice. All mice were clinically normal when 
tissues were collected. Homogenates (10% w/v) were 
prepared with sterile TBS in disposable tissue homogen- 
izers, clarified at 228g for 10 rain at 4 °C, and the 
supernatants were kept at -20  °C until used. Freshly 
thawed suspensions were briefly clarified at 11000 g at 
4 °C and bioassayed by i.c. inoculation in groups of four 
weanling BALB/c mice per donor spleen. Bioassay 
recipient mice were observed aily beginning at 112 days 
p.i. for clinical signs of scrapie and surviving animals 
were observed for 360 days. Tissues from representative 
animals were examined for lesions to confirm the clinical 
diagnosis. 
Infectivity was detectable in all spleens collected from 
ME7-inoculated BALB/c mice. Mean incubation times 
for recipients of spleens collected at 30, 60 and 90 days 
p.i. were 187, 168 and 184 days respectively (Table 2), 
consistent with the observation that splenic infectivity 
levels reach a plateau within 2 months following 
subcutaneous (Eklund et al., 1967) or i.c. inoculation 
(Race & Ernst, 1992). Recipients of inocula from the 
spleens of ME7-inoculated SCID mice were clinically 
normal throughout he 360 day observation period. 
Recipients of inocula from the spleens of uninoculated 
BALB/c and SCID mice also remained clinically normal. 
These observations demonstrate hat scrapie infectivity, 
as defined by mouse subinoculation, was not detectable 
in the spleens of scrapie-inoculated SCID mice during 
the first 90 days p.i. 
PrP s° accumulation was monitored by immunoblot 
analysis of tissues using the procedure described by Race 
& Ernst (1992) with slight modifications. Brains and 
spleens were collected from i.c. inoculated mice when 
they were terminally affected and from clinically normal, 
i.p. inoculated mice at 60 days p.i. Brains from individual 
mice or 200 to 250 mg aliquots of spleens from groups of 
three mice were prepared as 10 % (w/v) homogenates in 
sterile 0.01 M-Tris-HCI pH 7.5, 0.005M-MgC12 using 
disposable homogenizers, digested with DNase (final 
concentration 1U/ml) for 1 h at 37 °C, and kept at 
-20  °C until assayed. Samples were adjusted to 10% 
Sarkosyl, clarified at 10000g for 30 min at 20 °C and 
pelleted at 215000g for 2h at 4°C. Each pellet was 
resuspended in 1 ml of 0.01 M-Tris-HC1 pH 7.5 and 
incubated with proteinase K (10 lag per g starting tissue) 
for 30 rain at 37 °C. The suspension was adjusted to 
5 mM-PMSF and centrifuged at 212000 g for 1 h at 4 °C. 
Pellets were boiled in SDS-PAGE sample buffer (final 
SDS concentration 5 %) and stored at -20  °C until used 
for Western immunoblots. PrP s° preparations (repre- 
senting 1/2 spleen or 1/4 brain per lane) were electro- 
phoresed on 12% polyacrylamide gels (Pharmacia 
PhastSystem), transferred to PVDF membranes 
(Immobilon-P, Millipore) and probed with anti-PrP or 
control rabbit serum. Anti-PrP serum was prepared by 
inoculation of rabbits with the pentadecapeptide 
GQGGGTHNQWNKPSK (Shinagawa et al., 1986) 
synthesized as a multimeric macromolecule on a hepta- 
lysine backbone (serum R2843) (Tam, 1988) or coval- 
ently coupled to keyhole limpet haemocyanin (serum 
R27) (Wiley et al., 1987; Race et al., 1992). Bound rabbit 
antibody was detected with goat anti-rabbit IgG conju- 
gated to horseradish peroxidase followed by incubation 
with a chemiluminescent substrate (Amersham) diluted 
1:2 in distilled water. Membranes were exposed to ECL 
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Fig. 1. Immunoblots of PrP s~ preparations from SCID (lane 1) or 
BALB/c (lane 2) mouse spleen collected 60 days after i.p. inoculation 
with scrapie agent ME7. Brain (lane 4) or spleen (lane 5) from clinically 
affected i.c. inoculated SCID mouse, or control brain from an 
uninoculated BALB/c mouse (lane 3) was probed with rabbit anti-PrP 
peptide serum (R27) as described in text. 
Hyperfilm (Amersham) for intervals varying from 5 to 
60 s. Both antisera gave comparable staining patterns, 
although R27 was 50- to 100-fold more sensitive. 
PrP s° was detected in the brain but not the spleen of 
terminally affected, i.c. inoculated SCID mice (Fig. 1) 
and in both the brain and spleen of i.c. inoculated 
BALB/c mice. PrP s° was detected in BALB/c mouse 
spleen but not in SCID mouse spleen collected 60 days 
after i.p. inoculation. These findings are consistent with 
the observation that SCID mouse spleen does not 
accumulate PrP cJD following either i.c. or i.p. inoculation 
(Kitamoto et al., 1991). In that study, PrP cJD was 
undetectable in the spleen of a SCID mouse collected 500 
days after i.p. inoculation. 
In this study, we have demonstrated that the scrapie 
agent does not replicate in the spleens of SCID mice. 
Furthermore, PrP s~ does not accumulate in SCID mouse 
spleen following i.p. or i.c. inoculation with the scrapie 
agent. Failure of SCID mouse spleen to accumulate 
PrP sc or to harbour infectivity may be due to the 
lymphocyte deficiency, the failure of FDCs to mature, or 
to other less well characterized defects in SCID mice. 
Immunohistochemical evidence for PrP c and prpSc/ 
PrP cJD in FDCs is consistent with early experiments 
using cyclophosphamide-treated mice, which suggested 
that the tissue-associated non-mitotic cells (Worthington 
& Clark, 1971), rather than the circulating lymphocytes, 
are the site of agent replication. 
The association of the scrapie agent with antigen- 
trapping cells such as FDCs is of interest because the 
agent may replicate in that cell type or it may accumulate 
there after replication in other tissues and transport via 
the peripheral circulation (Tenner-Racz et al., 1985; 
Mori et al., 1991). Pre-clinical diagnostic testing of sheep 
by identification of PrP sc in lymphoid tissue has been 
proposed (Ikegami et al., 1991; Race et al., 1992; 
Onodera et al., 1993). The feasibility of such testing 
increases significantly if a circulating cell type containing 
infectivity or PrP s~ can be identified. Further discrimi- 
nation between endogenous and exogenous ources of 
the FDC-associated scrapie agent will be critical to our 
understanding of the extraneural pathogenesis of the 
TSEs. 
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assistance with manuscript preparation and Dr William Davis for 
critical review of the manuscript. Dr Richard Race provided antiserum 
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